Validation of PAG1 as a new risk gene with therapeutic potential for asthma
Validation of PAG1 as a new risk gene with therapeutic potential for asthma
批准号:
nhmrc : 1128493
负责人:
A/Pr Simon Phipps
金额:
$46.81万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 2019-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
About 10% of adults and children suffer from asthma in Australia. For >60% of these their asthma symptoms are not well controlled with existing treatments and so novel therapies are needed. We have recently identified PAG1 as a novel risk gene for asthma. In this study, we will conduct mouse and human studies to investigate the possibility inhibition of PAG1 might help prevent or treat asthma exacerbations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of necroptosis as a novel strategy for the prevention of bronchiolitis and subsequent asthma
-
批准号:nhmrc : 1141581
-
项目类别:Project Grants
-
资助金额:$44.49万
-
财政年份:2018
-
负责人:A/Pr Simon Phipps
-
依托单位:
Inhibition of necroptosis as a novel strategy for the prevention of bronchiolitis and subsequent asthma
-
批准号:nhmrc : GNT1141581
-
项目类别:Project Grants
-
资助金额:$65.8万
-
财政年份:2018
-
负责人:A/Pr Simon Phipps
-
依托单位:
Defective toll-like receptor 7 signalling in plasmacytoid dendritic cells underlies the inception of virus-associated asthma
-
批准号:nhmrc : 1023756
-
项目类别:Project Grants
-
资助金额:$36.83万
-
财政年份:2012
-
负责人:A/Pr Simon Phipps
-
依托单位:
The pathogenesis of distinct endophenotypes of asthma is underpinned by the collaborative activation of specific PRRs.
-
批准号:nhmrc : 631020
-
项目类别:NHMRC Project Grants
-
资助金额:$45.26万
-
财政年份:2010
-
负责人:A/Pr Simon Phipps
-
依托单位:
Pneumovirus infection in infancy affects the development of life-long adaptive immunity.
-
批准号:nhmrc : 510718
-
项目类别:NHMRC Project Grants
-
资助金额:$27.24万
-
财政年份:2008
-
负责人:A/Pr Simon Phipps
-
依托单位:
国内基金
海外基金
DNA去甲基化酶TET2联合转录因子ESR2激活PAG1抑制胃癌细胞耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:郭严
-
依托单位:
肿瘤抑制因子PAG1调控口腔鳞癌的分子机制研究
-
批准号:81902783
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2019
-
负责人:丛蓓蓓
-
依托单位:
PAG1诱导整合素β1活化介导喉癌原发性放射抗拒的机制
-
批准号:81502666
-
项目类别:青年科学基金项目
-
资助金额:16.5万元
-
批准年份:2015
-
负责人:沈力
-
依托单位: